125.96
+0.35(+0.28%)
Currency In USD
| Previous Close | 125.61 |
| Open | 124.83 |
| Day High | 127.33 |
| Day Low | 123.39 |
| 52-Week High | 219.34 |
| 52-Week Low | 122.8 |
| Volume | 356,438 |
| Average Volume | 339,207 |
| Market Cap | 3.64B |
| PE | 30.21 |
| EPS | 4.17 |
| Moving Average 50 Days | 157.67 |
| Moving Average 200 Days | 171.55 |
| Change | 0.35 |
If you invested $1000 in Krystal Biotech, Inc. (KRYS) since IPO date, it would be worth $11,838.35 as of June 01, 2025 at a share price of $125.96. Whereas If you bought $1000 worth of Krystal Biotech, Inc. (KRYS) shares 5 years ago, it would be worth $2,550.31 as of June 01, 2025 at a share price of $125.96.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan,
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire Inc.
Apr 28, 2025 11:00 AM GMT
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28, 202
Krystal Biotech to Present at Upcoming Scientific Conferences
GlobeNewswire Inc.
Apr 24, 2025 12:00 PM GMT
PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held in